var eventsData = [{"Ticker":"FFIV","EffectiveDate":"2017-01-25","Type":"EarningsBeatRevenueMiss","Title":"After market close, FFIV reports 2017 Q1's earning $1.98 per share and revenue $515.958MM. This beats analyst's estimated EPS $1.94, misses estimated revenue $517.97MM.","DailyReturn":0.0111,"FiveDayReturnAfter":-0.072791,"FiveDayReturnBefore":0.017636},{"Ticker":"FFIV","EffectiveDate":"2016-12-14","Type":"RatingUpgrade","Title":"Citigroup upgrades FFIV to Buy from Neutral.","DailyReturn":0.012082,"FiveDayReturnAfter":0.029076,"FiveDayReturnBefore":0.010595},{"Ticker":"FFIV","EffectiveDate":"2016-11-30","Type":"RatingNeutral","Title":"Bernstein downgrades FFIV to Market Perform from Outperform. Target Price is $140.","DailyReturn":-0.014425,"FiveDayReturnAfter":-0.013749,"FiveDayReturnBefore":-0.0067},{"Ticker":"FFIV","EffectiveDate":"2016-11-09","Type":"RatingUpgrade","Title":"Nomura upgrades FFIV to Neutral from Reduce. Target Price is $130; previously $115.","DailyReturn":0.017856,"FiveDayReturnAfter":0.040331,"FiveDayReturnBefore":0.005753},{"Ticker":"FFIV","EffectiveDate":"2016-10-27","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold.","DailyReturn":0.095784,"FiveDayReturnAfter":0.123991,"FiveDayReturnBefore":0.006631},{"Ticker":"FFIV","EffectiveDate":"2016-10-27","Type":"RatingUpgrade","Title":"PiperJaffray upgrades FFIV to Overweight from Neutral.","DailyReturn":0.095784,"FiveDayReturnAfter":0.123991,"FiveDayReturnBefore":0.006631},{"Ticker":"FFIV","EffectiveDate":"2016-10-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Neutral.","DailyReturn":0.095784,"FiveDayReturnAfter":0.123991,"FiveDayReturnBefore":0.006631},{"Ticker":"FFIV","EffectiveDate":"2016-10-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.019792,"FiveDayReturnAfter":0.155782,"FiveDayReturnBefore":-0.002896},{"Ticker":"FFIV","EffectiveDate":"2016-10-26","Type":"EarningsRevenueBeat","Title":"After market close, FFIV reports 2016 Q4's earning $2.11 per share and revenue $525.349MM. This beats analyst's estimated EPS $1.94, beats estimated revenue $520.45MM.","DailyReturn":0.019792,"FiveDayReturnAfter":0.155782,"FiveDayReturnBefore":-0.002896},{"Ticker":"FFIV","EffectiveDate":"2016-10-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.019792,"FiveDayReturnAfter":0.155782,"FiveDayReturnBefore":-0.002896},{"Ticker":"FFIV","EffectiveDate":"2016-09-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.008631,"FiveDayReturnAfter":0.033865,"FiveDayReturnBefore":0.016231},{"Ticker":"FFIV","EffectiveDate":"2016-09-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.008631,"FiveDayReturnAfter":0.033865,"FiveDayReturnBefore":0.016231},{"Ticker":"FFIV","EffectiveDate":"2016-09-14","Type":"RatingUpgrade","Title":"Oppenheimer upgrades FFIV to Outperform from Perform.","DailyReturn":0.009415,"FiveDayReturnAfter":0.013684,"FiveDayReturnBefore":-0.062938},{"Ticker":"FFIV","EffectiveDate":"2016-08-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.003605,"FiveDayReturnAfter":-0.003048,"FiveDayReturnBefore":0.006672},{"Ticker":"FFIV","EffectiveDate":"2016-08-12","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.00184,"FiveDayReturnAfter":-0.011019,"FiveDayReturnBefore":0.01369},{"Ticker":"FFIV","EffectiveDate":"2016-08-12","Type":"RatingNeutral","Title":"DA Davidson maintains FFIV to Buy. Target Price is $145; previously $125.34.","DailyReturn":-0.00184,"FiveDayReturnAfter":-0.011019,"FiveDayReturnBefore":0.01369},{"Ticker":"FFIV","EffectiveDate":"2016-07-21","Type":"RatingNeutral","Title":"Credit Suisse downgrades FFIV to Neutral from Outperform. Target Price is $125.","DailyReturn":0.003211,"FiveDayReturnAfter":0.013248,"FiveDayReturnBefore":0.042979},{"Ticker":"FFIV","EffectiveDate":"2016-07-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.007214,"FiveDayReturnAfter":0.028286,"FiveDayReturnBefore":0.023407},{"Ticker":"FFIV","EffectiveDate":"2016-07-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.007214,"FiveDayReturnAfter":0.028286,"FiveDayReturnBefore":0.023407},{"Ticker":"FFIV","EffectiveDate":"2016-07-20","Type":"EarningsRevenueBeat","Title":"After market close, FFIV reports 2016 Q3's earning $1.81 per share and revenue $496.522MM. This beats analyst's estimated EPS $1.79, beats estimated revenue $495.29MM.","DailyReturn":0.007214,"FiveDayReturnAfter":0.028286,"FiveDayReturnBefore":0.023407},{"Ticker":"FFIV","EffectiveDate":"2016-05-17","Type":"RatingNeutral","Title":"Pacific Crest downgrades FFIV to Sector Weight from Overweight.","DailyReturn":-0.03261,"FiveDayReturnAfter":-0.006356,"FiveDayReturnBefore":0.052308},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Citigroup maintains FFIV to Neutral. Target Price is $110; previously $95.","DailyReturn":0.055373,"FiveDayReturnAfter":0.095535,"FiveDayReturnBefore":0.000102},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Baird maintains FFIV to Neutral. Target Price is $110; previously $105.","DailyReturn":0.055373,"FiveDayReturnAfter":0.095535,"FiveDayReturnBefore":0.000102},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Buckingham Research maintains FFIV to Neutral. Target Price is $107; previously $105.","DailyReturn":0.055373,"FiveDayReturnAfter":0.095535,"FiveDayReturnBefore":0.000102},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Hold. Target Price is $99; previously $95.","DailyReturn":0.055373,"FiveDayReturnAfter":0.095535,"FiveDayReturnBefore":0.000102},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Neutral. Target Price is $119; previously $111.","DailyReturn":0.055373,"FiveDayReturnAfter":0.095535,"FiveDayReturnBefore":0.000102},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"EarningsBeatRevenueMiss","Title":"After market close, FFIV reports 2016 Q2's earning $1.68 per share and revenue $483.677MM. This beats analyst's estimated EPS $1.63, misses estimated revenue $485.93MM.","DailyReturn":0.01462,"FiveDayReturnAfter":0.095633,"FiveDayReturnBefore":0.005969},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.01462,"FiveDayReturnAfter":0.095633,"FiveDayReturnBefore":0.005969},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.01462,"FiveDayReturnAfter":0.095633,"FiveDayReturnBefore":0.005969},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.01462,"FiveDayReturnAfter":0.095633,"FiveDayReturnBefore":0.005969},{"Ticker":"FFIV","EffectiveDate":"2016-03-16","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.007879,"FiveDayReturnAfter":0.052727,"FiveDayReturnBefore":-0.007747},{"Ticker":"FFIV","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $5; previously $11.","DailyReturn":-0.000685,"FiveDayReturnAfter":0.043663,"FiveDayReturnBefore":-0.037195},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Market Perform. Target Price is $93; previously $108.","DailyReturn":-0.005665,"FiveDayReturnAfter":0.057418,"FiveDayReturnBefore":-0.028365},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Buckingham Research maintains FFIV to Neutral. Target Price is $105; previously $110.","DailyReturn":-0.005665,"FiveDayReturnAfter":0.057418,"FiveDayReturnBefore":-0.028365},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Hold. Target Price is $95; previously $100.","DailyReturn":-0.005665,"FiveDayReturnAfter":0.057418,"FiveDayReturnBefore":-0.028365},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Underweight. Target Price is $96; previously $98.","DailyReturn":-0.005665,"FiveDayReturnAfter":0.057418,"FiveDayReturnBefore":-0.028365},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains FFIV to Neutral. Target Price is $110; previously $115.","DailyReturn":-0.005665,"FiveDayReturnAfter":0.057418,"FiveDayReturnBefore":-0.028365},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $100; previously $115.","DailyReturn":-0.005665,"FiveDayReturnAfter":0.057418,"FiveDayReturnBefore":-0.028365},{"Ticker":"FFIV","EffectiveDate":"2016-01-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.037219,"FiveDayReturnAfter":0.03065,"FiveDayReturnBefore":-0.000214},{"Ticker":"FFIV","EffectiveDate":"2016-01-20","Type":"EarningsRevenueBeat","Title":"After market close, FFIV reports 2016 Q1's earning $1.73 per share and revenue $489.486MM. This beats analyst's estimated EPS $1.6, beats estimated revenue $485.62MM.","DailyReturn":-0.037219,"FiveDayReturnAfter":0.03065,"FiveDayReturnBefore":-0.000214},{"Ticker":"FFIV","EffectiveDate":"2016-01-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.037219,"FiveDayReturnAfter":0.03065,"FiveDayReturnBefore":-0.000214},{"Ticker":"FFIV","EffectiveDate":"2016-01-15","Type":"RatingNeutral","Title":"Sterne Agee CRT downgrades FFIV to Neutral from Buy.","DailyReturn":-0.006797,"FiveDayReturnAfter":-0.00415,"FiveDayReturnBefore":0.025164},{"Ticker":"FFIV","EffectiveDate":"2016-01-14","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Underweight from Equal-Weight. Target Price is $98; previously $123.","DailyReturn":0.001702,"FiveDayReturnAfter":-0.048943,"FiveDayReturnBefore":-0.010794},{"Ticker":"FFIV","EffectiveDate":"2016-01-14","Type":"RatingNeutral","Title":"RBC Capital maintains FFIV to Sector Perform. Target Price is $112; previously $115.","DailyReturn":0.001702,"FiveDayReturnAfter":-0.048943,"FiveDayReturnBefore":-0.010794},{"Ticker":"FFIV","EffectiveDate":"2016-01-13","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Overweight. Target Price is $109; previously $149.","DailyReturn":0.015009,"FiveDayReturnAfter":-0.028365,"FiveDayReturnBefore":-0.041354},{"Ticker":"FFIV","EffectiveDate":"2016-01-12","Type":"RatingNeutral","Title":"Deutsche Bank downgrades FFIV to Hold from Buy.","DailyReturn":-0.00973,"FiveDayReturnAfter":-0.000214,"FiveDayReturnBefore":-0.035815},{"Ticker":"FFIV","EffectiveDate":"2016-01-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.015541,"FiveDayReturnAfter":-0.041354,"FiveDayReturnBefore":-0.004961},{"Ticker":"FFIV","EffectiveDate":"2016-01-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.015541,"FiveDayReturnAfter":-0.041354,"FiveDayReturnBefore":-0.004961},{"Ticker":"FFIV","EffectiveDate":"2015-12-09","Type":"RatingNeutral","Title":"Nomura downgrades FFIV to Reduce from Neutral. Target Price is $90.","DailyReturn":-0.030063,"FiveDayReturnAfter":-0.036422,"FiveDayReturnBefore":-0.005206},{"Ticker":"FFIV","EffectiveDate":"2015-11-13","Type":"RatingNeutral","Title":"JMP Securities downgrades FFIV to Market Perform from Market Outperform.","DailyReturn":-0.040824,"FiveDayReturnAfter":-0.027078,"FiveDayReturnBefore":-0.030478},{"Ticker":"FFIV","EffectiveDate":"2015-11-13","Type":"RatingNeutral","Title":"William Blair downgrades FFIV to Market Perform from Outperform.","DailyReturn":-0.040824,"FiveDayReturnAfter":-0.027078,"FiveDayReturnBefore":-0.030478},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $123; previously $131.","DailyReturn":-0.092797,"FiveDayReturnAfter":-0.088975,"FiveDayReturnBefore":0.035824},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"Needham downgrades FFIV to Hold from Buy.","DailyReturn":-0.092797,"FiveDayReturnAfter":-0.088975,"FiveDayReturnBefore":0.035824},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"BMO Capital downgrades FFIV to Market Perform from Outperform. Target Price is $108; previously $140.","DailyReturn":-0.092797,"FiveDayReturnAfter":-0.088975,"FiveDayReturnBefore":0.035824},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"RBC Capital downgrades FFIV to Sector Perform from Outperform.","DailyReturn":-0.092797,"FiveDayReturnAfter":-0.088975,"FiveDayReturnBefore":0.035824},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"JMP Securities maintains FFIV to Market Outperform. Target Price is $125; previously $135.","DailyReturn":-0.092797,"FiveDayReturnAfter":-0.088975,"FiveDayReturnBefore":0.035824},{"Ticker":"FFIV","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.008729,"FiveDayReturnAfter":-0.064466,"FiveDayReturnBefore":0.00258},{"Ticker":"FFIV","EffectiveDate":"2015-10-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.008729,"FiveDayReturnAfter":-0.064466,"FiveDayReturnBefore":0.00258},{"Ticker":"FFIV","EffectiveDate":"2015-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.008729,"FiveDayReturnAfter":-0.064466,"FiveDayReturnBefore":0.00258},{"Ticker":"FFIV","EffectiveDate":"2015-10-14","Type":"RatingNeutral","Title":"Barclays initiates coverage on FFIV to Equal-Weight. Target Price is $131.","DailyReturn":-0.026115,"FiveDayReturnAfter":-0.005319,"FiveDayReturnBefore":0.022299},{"Ticker":"FFIV","EffectiveDate":"2015-10-06","Type":"RatingNeutral","Title":"Citigroup initiates coverage on FFIV to Sell. Target Price is $105.","DailyReturn":-0.040508,"FiveDayReturnAfter":-0.029218,"FiveDayReturnBefore":0.074797},{"Ticker":"FFIV","EffectiveDate":"2015-09-25","Type":"RatingNeutral","Title":"Raymond James downgrades FFIV to Market Perform.","DailyReturn":-0.009493,"FiveDayReturnAfter":0.00945,"FiveDayReturnBefore":-0.020077},{"Ticker":"FFIV","EffectiveDate":"2015-09-22","Type":"RatingNeutral","Title":"Guggenheim downgrades FFIV to Neutral.","DailyReturn":-0.021673,"FiveDayReturnAfter":-0.015049,"FiveDayReturnBefore":-0.010991},{"Ticker":"FFIV","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $145; previously $140.","DailyReturn":-0.021917,"FiveDayReturnAfter":-0.028583,"FiveDayReturnBefore":0.050847},{"Ticker":"FFIV","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Buckingham Research downgrades FFIV to Neutral from Buy.","DailyReturn":-0.021917,"FiveDayReturnAfter":-0.028583,"FiveDayReturnBefore":0.050847},{"Ticker":"FFIV","EffectiveDate":"2015-07-23","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $140; previously $127.","DailyReturn":0.077468,"FiveDayReturnAfter":0.111595,"FiveDayReturnBefore":0.005501},{"Ticker":"FFIV","EffectiveDate":"2015-07-22","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.001945,"FiveDayReturnAfter":0.10619,"FiveDayReturnBefore":0.000169},{"Ticker":"FFIV","EffectiveDate":"2015-07-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.001945,"FiveDayReturnAfter":0.10619,"FiveDayReturnBefore":0.000169},{"Ticker":"FFIV","EffectiveDate":"2015-07-06","Type":"RatingNeutral","Title":"Oppenheimer maintains FFIV to Outperform. Target Price is $133; previously $145.","DailyReturn":-0.023995,"FiveDayReturnAfter":-0.034204,"FiveDayReturnBefore":-0.049486},{"Ticker":"FFIV","EffectiveDate":"2015-06-29","Type":"RatingNeutral","Title":"PiperJaffray downgrades FFIV to Neutral from Overweight. Target Price is $130.","DailyReturn":-0.028486,"FiveDayReturnAfter":-0.049944,"FiveDayReturnBefore":-0.02675},{"Ticker":"FFIV","EffectiveDate":"2015-06-03","Type":"RatingNeutral","Title":"Nomura initiates coverage on FFIV to Neutral. Target Price is $118.","DailyReturn":0.007904,"FiveDayReturnAfter":-0.004562,"FiveDayReturnBefore":-0.006526},{"Ticker":"FFIV","EffectiveDate":"2015-06-01","Type":"RatingNeutral","Title":"Citigroup downgrades FFIV to Neutral from Buy. Target Price is $132; previously $122.","DailyReturn":-0.004615,"FiveDayReturnAfter":-0.009353,"FiveDayReturnBefore":-0.009581},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingUpgrade","Title":"Needham upgrades FFIV to Buy from Hold.","DailyReturn":0.016442,"FiveDayReturnAfter":0.027277,"FiveDayReturnBefore":0.027871},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"MKM Partners downgrades FFIV to Neutral from Buy.","DailyReturn":0.016442,"FiveDayReturnAfter":0.027277,"FiveDayReturnBefore":0.027871},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $140.","DailyReturn":0.016442,"FiveDayReturnAfter":0.027277,"FiveDayReturnBefore":0.027871},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $130; previously $128.","DailyReturn":0.016442,"FiveDayReturnAfter":0.027277,"FiveDayReturnBefore":0.027871},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Overweight. Target Price is $149; previously $141.","DailyReturn":0.016442,"FiveDayReturnAfter":0.027277,"FiveDayReturnBefore":0.027871},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.012528,"FiveDayReturnAfter":0.054486,"FiveDayReturnBefore":0.048143},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.012528,"FiveDayReturnAfter":0.054486,"FiveDayReturnBefore":0.048143},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.012528,"FiveDayReturnAfter":0.054486,"FiveDayReturnBefore":0.048143},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.012528,"FiveDayReturnAfter":0.054486,"FiveDayReturnBefore":0.048143},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.012528,"FiveDayReturnAfter":0.054486,"FiveDayReturnBefore":0.048143},{"Ticker":"FFIV","EffectiveDate":"2015-03-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006003,"FiveDayReturnAfter":0.018804,"FiveDayReturnBefore":-0.01368},{"Ticker":"FFIV","EffectiveDate":"2015-03-17","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.006003,"FiveDayReturnAfter":0.018804,"FiveDayReturnBefore":-0.01368},{"Ticker":"FFIV","EffectiveDate":"2015-03-17","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.006003,"FiveDayReturnAfter":0.018804,"FiveDayReturnBefore":-0.01368},{"Ticker":"FFIV","EffectiveDate":"2015-03-09","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Underperform from Equal-Weight. Target Price is $114.","DailyReturn":-0.026534,"FiveDayReturnAfter":-0.048638,"FiveDayReturnBefore":-0.001356},{"Ticker":"FFIV","EffectiveDate":"2015-03-04","Type":"RatingNeutral","Title":"Wedbush initiates coverage on FFIV to Outperform. Target Price is $140.","DailyReturn":0.001933,"FiveDayReturnAfter":-0.058122,"FiveDayReturnBefore":-0.004946},{"Ticker":"FFIV","EffectiveDate":"2015-01-23","Type":"RatingNeutral","Title":"Citigroup maintains FFIV to Buy. Target Price is $122; previously $135.","DailyReturn":0.012787,"FiveDayReturnAfter":0.005102,"FiveDayReturnBefore":-0.102181},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $114; previously $136.","DailyReturn":-0.099643,"FiveDayReturnAfter":-0.109914,"FiveDayReturnBefore":-0.021365},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades FFIV to Hold from Buy.","DailyReturn":-0.099643,"FiveDayReturnAfter":-0.109914,"FiveDayReturnBefore":-0.021365},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $140; previously $150.","DailyReturn":-0.099643,"FiveDayReturnAfter":-0.109914,"FiveDayReturnBefore":-0.021365},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingUpgrade","Title":"Buckingham Research upgrades FFIV to Buy from Neutral.","DailyReturn":-0.099643,"FiveDayReturnAfter":-0.109914,"FiveDayReturnBefore":-0.021365},{"Ticker":"FFIV","EffectiveDate":"2015-01-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.002376,"FiveDayReturnAfter":-0.109196,"FiveDayReturnBefore":-0.01314},{"Ticker":"FFIV","EffectiveDate":"2015-01-21","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.002376,"FiveDayReturnAfter":-0.109196,"FiveDayReturnBefore":-0.01314},{"Ticker":"FFIV","EffectiveDate":"2015-01-21","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.002376,"FiveDayReturnAfter":-0.109196,"FiveDayReturnBefore":-0.01314},{"Ticker":"FFIV","EffectiveDate":"2015-01-14","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Equal-Weight from Overweight. Target Price is $136.","DailyReturn":-0.023859,"FiveDayReturnAfter":-0.021365,"FiveDayReturnBefore":0.015191},{"Ticker":"FFIV","EffectiveDate":"2015-01-06","Type":"RatingNeutral","Title":"Needham downgrades FFIV to Hold from Buy.","DailyReturn":-0.023351,"FiveDayReturnAfter":-0.014283,"FiveDayReturnBefore":-0.029615},{"Ticker":"FFIV","EffectiveDate":"2015-01-05","Type":"RatingUpgrade","Title":"Oppenheimer upgrades FFIV to Outperform from Market Perform. Target Price is $160.","DailyReturn":-0.004374,"FiveDayReturnAfter":-0.003384,"FiveDayReturnBefore":-0.036021},{"Ticker":"FFIV","EffectiveDate":"2014-11-14","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $130; previously $115.","DailyReturn":0.021641,"FiveDayReturnAfter":0.014326,"FiveDayReturnBefore":0.007478},{"Ticker":"FFIV","EffectiveDate":"2014-10-31","Type":"RatingNeutral","Title":"Citigroup maintains FFIV to Buy. Target Price is $135; previously $120.","DailyReturn":0.009854,"FiveDayReturnAfter":0.027777,"FiveDayReturnBefore":0.06103},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains FFIV to Buy. Target Price is $145; previously $134.","DailyReturn":0.039788,"FiveDayReturnAfter":0.068469,"FiveDayReturnBefore":0.038115},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $118; previously $113.","DailyReturn":0.039788,"FiveDayReturnAfter":0.068469,"FiveDayReturnBefore":0.038115},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $115; previously $108.5.","DailyReturn":0.039788,"FiveDayReturnAfter":0.068469,"FiveDayReturnBefore":0.038115},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $136; previously $126.","DailyReturn":0.039788,"FiveDayReturnAfter":0.068469,"FiveDayReturnBefore":0.038115},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.026029,"FiveDayReturnAfter":0.043848,"FiveDayReturnBefore":0.030738},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.026029,"FiveDayReturnAfter":0.043848,"FiveDayReturnBefore":0.030738},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.026029,"FiveDayReturnAfter":0.043848,"FiveDayReturnBefore":0.030738},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.026029,"FiveDayReturnAfter":0.043848,"FiveDayReturnBefore":0.030738},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.026029,"FiveDayReturnAfter":0.043848,"FiveDayReturnBefore":0.030738},{"Ticker":"FFIV","EffectiveDate":"2014-10-14","Type":"RatingNeutral","Title":"Morgan Stanley maintains FFIV to Equal-Weight. Target Price is $113.","DailyReturn":0.006507,"FiveDayReturnAfter":0.033968,"FiveDayReturnBefore":-0.112976},{"Ticker":"FFIV","EffectiveDate":"2014-10-14","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on FFIV to Outperform. Target Price is $140.","DailyReturn":0.006507,"FiveDayReturnAfter":0.033968,"FiveDayReturnBefore":-0.112976},{"Ticker":"FFIV","EffectiveDate":"2014-10-07","Type":"RatingNeutral","Title":"Bank of America maintains FFIV to Neutral. Target Price is $138; previously $120.","DailyReturn":-0.03479,"FiveDayReturnAfter":-0.112976,"FiveDayReturnBefore":0.024864},{"Ticker":"FFIV","EffectiveDate":"2014-09-29","Type":"RatingNeutral","Title":"Baird downgrades FFIV to Neutral from Outperform. Target Price is $125.","DailyReturn":-0.015532,"FiveDayReturnAfter":0.013213,"FiveDayReturnBefore":-0.030912},{"Ticker":"FFIV","EffectiveDate":"2014-09-11","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $150; previously $135.","DailyReturn":0.007429,"FiveDayReturnAfter":0.001995,"FiveDayReturnBefore":0.010278},{"Ticker":"FFIV","EffectiveDate":"2014-08-19","Type":"RatingUpgrade","Title":"ISI Group upgrades FFIV to Strong Buy from Buy.","DailyReturn":0.029596,"FiveDayReturnAfter":0.041832,"FiveDayReturnBefore":-0.001628},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $108.5; previously $101.","DailyReturn":0.021839,"FiveDayReturnAfter":0.042925,"FiveDayReturnBefore":0.010157},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $112; previously $110.","DailyReturn":0.021839,"FiveDayReturnAfter":0.042925,"FiveDayReturnBefore":0.010157},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $114; previously $112.","DailyReturn":0.021839,"FiveDayReturnAfter":0.042925,"FiveDayReturnBefore":0.010157},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $126; previously $123.","DailyReturn":0.021839,"FiveDayReturnAfter":0.042925,"FiveDayReturnBefore":0.010157},{"Ticker":"FFIV","EffectiveDate":"2014-07-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011684,"FiveDayReturnAfter":0.019169,"FiveDayReturnBefore":0.012563},{"Ticker":"FFIV","EffectiveDate":"2014-07-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.011684,"FiveDayReturnAfter":0.019169,"FiveDayReturnBefore":0.012563},{"Ticker":"FFIV","EffectiveDate":"2014-07-09","Type":"RatingNeutral","Title":"D.A. Davidson initiates coverage on FFIV to Buy. Target Price is $145.","DailyReturn":0.023727,"FiveDayReturnAfter":0.014192,"FiveDayReturnBefore":-0.020672},{"Ticker":"FFIV","EffectiveDate":"2014-06-19","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on FFIV to Neutral. Target Price is $128.","DailyReturn":-0.026835,"FiveDayReturnAfter":-0.032971,"FiveDayReturnBefore":0.001512},{"Ticker":"FFIV","EffectiveDate":"2014-06-18","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on FFIV to Equal-weight.","DailyReturn":-0.008982,"FiveDayReturnAfter":-0.036773,"FiveDayReturnBefore":0.008579},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $113; previously $111.","DailyReturn":-0.020427,"FiveDayReturnAfter":-0.028311,"FiveDayReturnBefore":0.004261},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $123; previously $120.","DailyReturn":-0.020427,"FiveDayReturnAfter":-0.028311,"FiveDayReturnBefore":0.004261},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $130.","DailyReturn":-0.020427,"FiveDayReturnAfter":-0.028311,"FiveDayReturnBefore":0.004261},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $112; previously $105.","DailyReturn":-0.020427,"FiveDayReturnAfter":-0.028311,"FiveDayReturnBefore":0.004261},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Outperform. Target Price is $133; previously $120.","DailyReturn":-0.020427,"FiveDayReturnAfter":-0.028311,"FiveDayReturnBefore":0.004261},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Bank of America maintains FFIV to Neutral. Target Price is $120; previously $112.","DailyReturn":-0.020427,"FiveDayReturnAfter":-0.028311,"FiveDayReturnBefore":0.004261},{"Ticker":"FFIV","EffectiveDate":"2014-04-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.00943,"FiveDayReturnAfter":-0.036836,"FiveDayReturnBefore":0.020068},{"Ticker":"FFIV","EffectiveDate":"2014-04-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00943,"FiveDayReturnAfter":-0.036836,"FiveDayReturnBefore":0.020068},{"Ticker":"FFIV","EffectiveDate":"2014-04-14","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades FFIV to Buy from Hold. Target Price is $120.","DailyReturn":0.03922,"FiveDayReturnAfter":0.05441,"FiveDayReturnBefore":-0.013788},{"Ticker":"FFIV","EffectiveDate":"2014-04-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.012179,"FiveDayReturnAfter":0.038749,"FiveDayReturnBefore":-0.025469},{"Ticker":"FFIV","EffectiveDate":"2014-04-11","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.012179,"FiveDayReturnAfter":0.038749,"FiveDayReturnBefore":-0.025469},{"Ticker":"FFIV","EffectiveDate":"2014-04-10","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on FFIV to Neutral. Target Price is $116.","DailyReturn":-0.049841,"FiveDayReturnAfter":-0.013208,"FiveDayReturnBefore":0.00475},{"Ticker":"FFIV","EffectiveDate":"2014-04-04","Type":"RatingNeutral","Title":"Northland initiates coverage on FFIV to Market Perform. Target Price is $113.","DailyReturn":-0.023651,"FiveDayReturnAfter":-0.025469,"FiveDayReturnBefore":0.00619},{"Ticker":"FFIV","EffectiveDate":"2014-03-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.036911,"FiveDayReturnAfter":0.01635,"FiveDayReturnBefore":-0.026872},{"Ticker":"FFIV","EffectiveDate":"2014-02-10","Type":"RatingNeutral","Title":"Dougherty initiates coverage on FFIV to Buy. Target Price is $125.","DailyReturn":0.020694,"FiveDayReturnAfter":0.042253,"FiveDayReturnBefore":0.002425},{"Ticker":"FFIV","EffectiveDate":"2014-01-23","Type":"RatingNeutral","Title":"Nomura downgrades FFIV to Neutral from Buy. Target Price is $111; previously $100.","DailyReturn":0.051395,"FiveDayReturnAfter":0.097658,"FiveDayReturnBefore":0.030837},{"Ticker":"FFIV","EffectiveDate":"2014-01-23","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $100; previously $90.","DailyReturn":0.051395,"FiveDayReturnAfter":0.097658,"FiveDayReturnBefore":0.030837},{"Ticker":"FFIV","EffectiveDate":"2014-01-23","Type":"RatingNeutral","Title":"McAdams Wright Ragen downgrades FFIV to Hold from Buy.","DailyReturn":0.051395,"FiveDayReturnAfter":0.097658,"FiveDayReturnBefore":0.030837},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.007332,"FiveDayReturnAfter":0.111108,"FiveDayReturnBefore":0.065111},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.007332,"FiveDayReturnAfter":0.111108,"FiveDayReturnBefore":0.065111},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"RatingNeutral","Title":"Nomura downgrades FFIV to Neutral from Buy. Target Price is $111; previously $100.","DailyReturn":-0.007332,"FiveDayReturnAfter":0.111108,"FiveDayReturnBefore":0.065111},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.007332,"FiveDayReturnAfter":0.111108,"FiveDayReturnBefore":0.065111},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"RatingUpgrade","Title":"Janney Capital upgrades FFIV to Buy from Neutral. Target Price is $122; previously $83.","DailyReturn":-0.007332,"FiveDayReturnAfter":0.111108,"FiveDayReturnBefore":0.065111},{"Ticker":"FFIV","EffectiveDate":"2014-01-13","Type":"RatingNeutral","Title":"William Blair downgrades FFIV to Outperform from Market Perform.","DailyReturn":0.039426,"FiveDayReturnAfter":0.090659,"FiveDayReturnBefore":0.005551},{"Ticker":"FFIV","EffectiveDate":"2013-12-11","Type":"RatingNeutral","Title":"Citigroup initiates coverage on FFIV to Buy. Target Price is $100.","DailyReturn":-0.005666,"FiveDayReturnAfter":-0.005562,"FiveDayReturnBefore":0.031658},{"Ticker":"FFIV","EffectiveDate":"2013-11-22","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.000362,"FiveDayReturnAfter":-0.007872,"FiveDayReturnBefore":-0.013655},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $90; previously $88.","DailyReturn":-0.01344,"FiveDayReturnAfter":-0.033219,"FiveDayReturnBefore":-0.025282},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Buy. Target Price is $100; previously $97.","DailyReturn":-0.01344,"FiveDayReturnAfter":-0.033219,"FiveDayReturnBefore":-0.025282},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Bank of America downgrades FFIV to Neutral from Buy.","DailyReturn":-0.01344,"FiveDayReturnAfter":-0.033219,"FiveDayReturnBefore":-0.025282},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $107; previously $100.","DailyReturn":-0.01344,"FiveDayReturnAfter":-0.033219,"FiveDayReturnBefore":-0.025282},{"Ticker":"FFIV","EffectiveDate":"2013-10-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.047876,"FiveDayReturnAfter":-0.074286,"FiveDayReturnBefore":0.034796},{"Ticker":"FFIV","EffectiveDate":"2013-10-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.047876,"FiveDayReturnAfter":-0.074286,"FiveDayReturnBefore":0.034796},{"Ticker":"FFIV","EffectiveDate":"2013-10-22","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Outperform.","DailyReturn":0.005993,"FiveDayReturnAfter":-0.066886,"FiveDayReturnBefore":-0.001109},{"Ticker":"FFIV","EffectiveDate":"2013-09-24","Type":"RatingNeutral","Title":"Goldman Sachs downgrades FFIV to Neutral from Buy. Target Price is $93.","DailyReturn":-0.02355,"FiveDayReturnAfter":-0.03841,"FiveDayReturnBefore":-0.018996},{"Ticker":"FFIV","EffectiveDate":"2013-09-19","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on FFIV to Buy. Target Price is $110.","DailyReturn":0.001721,"FiveDayReturnAfter":-0.054732,"FiveDayReturnBefore":0.00995},{"Ticker":"FFIV","EffectiveDate":"2013-08-12","Type":"RatingUpgrade","Title":"Barclays upgrades FFIV to Overweight from Equal-Weight. Target Price is $107; previously $89.","DailyReturn":0.031375,"FiveDayReturnAfter":-0.026951,"FiveDayReturnBefore":0.016038},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Buy. Target Price is $97; previously $88.","DailyReturn":0.072095,"FiveDayReturnAfter":0.075441,"FiveDayReturnBefore":0.006408},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $88; previously $85.","DailyReturn":0.072095,"FiveDayReturnAfter":0.075441,"FiveDayReturnBefore":0.006408},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $89; previously $81.","DailyReturn":0.072095,"FiveDayReturnAfter":0.075441,"FiveDayReturnBefore":0.006408},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":null,"DailyReturn":0.072095,"FiveDayReturnAfter":0.075441,"FiveDayReturnBefore":0.006408},{"Ticker":"FFIV","EffectiveDate":"2013-07-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.018896,"FiveDayReturnAfter":0.095186,"FiveDayReturnBefore":-0.006485},{"Ticker":"FFIV","EffectiveDate":"2013-07-24","Type":"EarningBeat","Title":"FFIV reports 2013 Q3's earning $1.12 per share and revenue $370.3MM. This beats analyst's estimated EPS $1.08.","DailyReturn":0.018896,"FiveDayReturnAfter":0.095186,"FiveDayReturnBefore":-0.006485},{"Ticker":"FFIV","EffectiveDate":"2013-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.018896,"FiveDayReturnAfter":0.095186,"FiveDayReturnBefore":-0.006485},{"Ticker":"FFIV","EffectiveDate":"2013-07-12","Type":"RatingUpgrade","Title":"PiperJaffray upgrades FFIV to Overweight from Neutral.","DailyReturn":0.048627,"FiveDayReturnAfter":0.071627,"FiveDayReturnBefore":0.093182},{"Ticker":"FFIV","EffectiveDate":"2013-07-12","Type":"RatingUpgrade","Title":"PiperJaffray upgrades FFIV to Overweight from Neutral. Target Price is $88; previously $80.","DailyReturn":0.048627,"FiveDayReturnAfter":0.071627,"FiveDayReturnBefore":0.093182},{"Ticker":"FFIV","EffectiveDate":"2013-06-28","Type":"RatingUpgrade","Title":"Raymond James upgrades FFIV to Outperform from Market Perform.","DailyReturn":-0.017844,"FiveDayReturnAfter":-0.012353,"FiveDayReturnBefore":-0.031891},{"Ticker":"FFIV","EffectiveDate":"2013-06-03","Type":"RatingNeutral","Title":"Morgan Stanley downgrades FFIV to Equal-Weight from Overweight.","DailyReturn":-0.048672,"FiveDayReturnAfter":-0.063761,"FiveDayReturnBefore":0.024206},{"Ticker":"FFIV","EffectiveDate":"2013-05-07","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on FFIV to Outperform.","DailyReturn":-0.007224,"FiveDayReturnAfter":0.010521,"FiveDayReturnBefore":0.020329},{"Ticker":"FFIV","EffectiveDate":"2013-04-26","Type":"RatingNeutral","Title":"FBR Capital downgrades FFIV to Market Perform from Outperform. Target Price is $75; previously $120.","DailyReturn":-0.009214,"FiveDayReturnAfter":-0.005222,"FiveDayReturnBefore":0.031883},{"Ticker":"FFIV","EffectiveDate":"2013-04-25","Type":"RatingUpgrade","Title":"Nomura upgrades FFIV to Buy from Neutral. Target Price is $88; previously $85.","DailyReturn":0.035107,"FiveDayReturnAfter":0.024169,"FiveDayReturnBefore":-0.015633},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.000276,"FiveDayReturnAfter":0.055135,"FiveDayReturnBefore":-0.022014},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.000276,"FiveDayReturnAfter":0.055135,"FiveDayReturnBefore":-0.022014},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.000276,"FiveDayReturnAfter":0.055135,"FiveDayReturnBefore":-0.022014},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"RevenueBeat","Title":"After market close, FFIV reports 2013 Q2's earning $1.07 per share and revenue $350.2MM. This meets analyst's estimated EPS $1.07, misses estimated revenue $351.78MM.","DailyReturn":0.000276,"FiveDayReturnAfter":0.055135,"FiveDayReturnBefore":-0.022014},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $80; previously $120.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Topeka downgrades FFIV to Hold from Buy. Target Price is $70; previously $118.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $82; previously $91.5.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Sterne Agee maintains FFIV to Buy. Target Price is $95; previously $118.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $85; previously $105.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $90; previously $112.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"PiperJaffray downgrades FFIV to Neutral from Overweight. Target Price is $82; previously $107.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"ISI Group maintains FFIV to Buy. Target Price is $95; previously $125.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Citigroup downgrades FFIV to Neutral from Buy. Target Price is $80; previously $125.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Buy. Target Price is $98; previously $111.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $85; previously $104.","DailyReturn":-0.190334,"FiveDayReturnAfter":-0.175047,"FiveDayReturnBefore":0.01898},{"Ticker":"FFIV","EffectiveDate":"2013-04-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.001105,"FiveDayReturnAfter":-0.209646,"FiveDayReturnBefore":0.033133},{"Ticker":"FFIV","EffectiveDate":"2013-04-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.001105,"FiveDayReturnAfter":-0.209646,"FiveDayReturnBefore":0.033133},{"Ticker":"FFIV","EffectiveDate":"2013-04-03","Type":"RatingNeutral","Title":"Craig-Hallum initiates coverage on FFIV to Buy. Target Price is $110.","DailyReturn":0.007681,"FiveDayReturnAfter":-0.215022,"FiveDayReturnBefore":0.026509},{"Ticker":"FFIV","EffectiveDate":"2013-04-02","Type":"RatingUpgrade","Title":"Baird upgrades FFIV to Outperform from Neutral. Target Price is $110.","DailyReturn":0.02184,"FiveDayReturnAfter":-0.18901,"FiveDayReturnBefore":0.010291},{"Ticker":"FFIV","EffectiveDate":"2013-03-27","Type":"RatingUpgrade","Title":"McAdams Wright Ragen upgrades FFIV to Buy from Hold. Target Price is $110.","DailyReturn":0.013132,"FiveDayReturnAfter":0.033133,"FiveDayReturnBefore":-0.024032},{"Ticker":"FFIV","EffectiveDate":"2013-03-22","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $90; previously $105.","DailyReturn":-0.022689,"FiveDayReturnAfter":0.000562,"FiveDayReturnBefore":-0.025287},{"Ticker":"FFIV","EffectiveDate":"2013-03-13","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.007169,"FiveDayReturnAfter":-0.041064,"FiveDayReturnBefore":0.00032},{"Ticker":"FFIV","EffectiveDate":"2013-03-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.007169,"FiveDayReturnAfter":-0.041064,"FiveDayReturnBefore":0.00032},{"Ticker":"FFIV","EffectiveDate":"2013-03-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.007169,"FiveDayReturnAfter":-0.041064,"FiveDayReturnBefore":0.00032},{"Ticker":"FFIV","EffectiveDate":"2013-01-25","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $110; previously $100.","DailyReturn":0.021411,"FiveDayReturnAfter":0.015955,"FiveDayReturnBefore":0.058859},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $104; previously $100.","DailyReturn":0.044631,"FiveDayReturnAfter":0.060286,"FiveDayReturnBefore":0.013962},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $105; previously $100.","DailyReturn":0.044631,"FiveDayReturnAfter":0.060286,"FiveDayReturnBefore":0.013962},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $107; previously $106.","DailyReturn":0.044631,"FiveDayReturnAfter":0.060286,"FiveDayReturnBefore":0.013962},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $105; previously $90.","DailyReturn":0.044631,"FiveDayReturnAfter":0.060286,"FiveDayReturnBefore":0.013962},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $120; previously $115.","DailyReturn":0.044631,"FiveDayReturnAfter":0.060286,"FiveDayReturnBefore":0.013962},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"McAdams Wright Ragen maintains FFIV to Hold. Target Price is $110.","DailyReturn":0.044631,"FiveDayReturnAfter":0.060286,"FiveDayReturnBefore":0.013962},{"Ticker":"FFIV","EffectiveDate":"2013-01-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.021926,"FiveDayReturnAfter":0.08064,"FiveDayReturnBefore":-0.005158},{"Ticker":"FFIV","EffectiveDate":"2013-01-23","Type":"EarningsRevenueMiss","Title":"After market close, FFIV reports 2013 Q1's earning $1.14 per share and revenue $365.5MM. This misses analyst's estimated EPS $1.15, misses estimated revenue $366.91MM.","DailyReturn":0.021926,"FiveDayReturnAfter":0.08064,"FiveDayReturnBefore":-0.005158},{"Ticker":"FFIV","EffectiveDate":"2013-01-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.021926,"FiveDayReturnAfter":0.08064,"FiveDayReturnBefore":-0.005158},{"Ticker":"FFIV","EffectiveDate":"2013-01-22","Type":"RatingNeutral","Title":"Needham downgrades FFIV to Hold from Buy.","DailyReturn":-0.002064,"FiveDayReturnAfter":0.086652,"FiveDayReturnBefore":-0.010269},{"Ticker":"FFIV","EffectiveDate":"2013-01-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.038176,"FiveDayReturnAfter":-0.055409,"FiveDayReturnBefore":0.049883},{"Ticker":"FFIV","EffectiveDate":"2013-01-03","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.038176,"FiveDayReturnAfter":-0.055409,"FiveDayReturnBefore":0.049883},{"Ticker":"FFIV","EffectiveDate":"2013-01-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.038176,"FiveDayReturnAfter":-0.055409,"FiveDayReturnBefore":0.049883},{"Ticker":"FFIV","EffectiveDate":"2012-12-21","Type":"RatingNeutral","Title":"FBR Capital initiates coverage on FFIV to Outperform. Target Price is $120.","DailyReturn":0.001336,"FiveDayReturnAfter":-0.012303,"FiveDayReturnBefore":0.037689},{"Ticker":"FFIV","EffectiveDate":"2012-12-20","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $95; previously $83.","DailyReturn":0.009229,"FiveDayReturnAfter":0.007129,"FiveDayReturnBefore":0.023501},{"Ticker":"FFIV","EffectiveDate":"2012-12-19","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $110; previously $95.","DailyReturn":-0.008737,"FiveDayReturnAfter":0.000617,"FiveDayReturnBefore":0.024662},{"Ticker":"FFIV","EffectiveDate":"2012-11-13","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades FFIV to Buy from Neutral. Target Price is $106; previously $104.","DailyReturn":0.004644,"FiveDayReturnAfter":0.022272,"FiveDayReturnBefore":0.011794},{"Ticker":"FFIV","EffectiveDate":"2012-10-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.009905,"FiveDayReturnAfter":0.069548,"FiveDayReturnBefore":-0.158648},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $100; previously $109.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Wunderlich downgrades FFIV to Hold from Buy. Target Price is $100; previously $115.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $115; previously $125.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Oppenheimer downgrades FFIV to Perform from Outperform.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $90; previously $110.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $90; previously $105.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $100; previously $120.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $116; previously $136.","DailyReturn":-0.110587,"FiveDayReturnAfter":-0.122146,"FiveDayReturnBefore":-0.042073},{"Ticker":"FFIV","EffectiveDate":"2012-10-24","Type":"EarningsRevenueMiss","Title":"After market close, FFIV reports 2012 Q4's earning $1.12 per share and revenue $362.6MM. This misses analyst's estimated EPS $1.18, misses estimated revenue $365.87MM.","DailyReturn":-0.023236,"FiveDayReturnAfter":-0.104035,"FiveDayReturnBefore":-0.057456},{"Ticker":"FFIV","EffectiveDate":"2012-10-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.023236,"FiveDayReturnAfter":-0.104035,"FiveDayReturnBefore":-0.057456},{"Ticker":"FFIV","EffectiveDate":"2012-10-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.023236,"FiveDayReturnAfter":-0.104035,"FiveDayReturnBefore":-0.057456},{"Ticker":"FFIV","EffectiveDate":"2012-10-15","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.010692,"FiveDayReturnAfter":-0.014811,"FiveDayReturnBefore":-0.061404},{"Ticker":"FFIV","EffectiveDate":"2012-10-15","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.010692,"FiveDayReturnAfter":-0.014811,"FiveDayReturnBefore":-0.061404},{"Ticker":"FFIV","EffectiveDate":"2012-10-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010692,"FiveDayReturnAfter":-0.014811,"FiveDayReturnBefore":-0.061404},{"Ticker":"FFIV","EffectiveDate":"2012-10-09","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on FFIV to Neutral.","DailyReturn":-0.017328,"FiveDayReturnAfter":-0.055111,"FiveDayReturnBefore":-0.007767},{"Ticker":"FFIV","EffectiveDate":"2012-10-05","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Equal-Weight from Overweight. Target Price is $105; previously $115.","DailyReturn":-0.037234,"FiveDayReturnAfter":-0.083843,"FiveDayReturnBefore":0.008695},{"Ticker":"FFIV","EffectiveDate":"2012-10-05","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Equal-Weight from Overweight.","DailyReturn":-0.037234,"FiveDayReturnAfter":-0.083843,"FiveDayReturnBefore":0.008695},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $99; previously $101.","DailyReturn":0.042195,"FiveDayReturnAfter":-0.069398,"FiveDayReturnBefore":0.064194},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Neutral. Target Price is $109; previously $123.","DailyReturn":0.042195,"FiveDayReturnAfter":-0.069398,"FiveDayReturnBefore":0.064194},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $136; previously $140.","DailyReturn":0.042195,"FiveDayReturnAfter":-0.069398,"FiveDayReturnBefore":0.064194},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"McAdams Wright Ragen maintains FFIV to Hold. Target Price is $120; previously $130.","DailyReturn":0.042195,"FiveDayReturnAfter":-0.069398,"FiveDayReturnBefore":0.064194},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $130; previously $150.","DailyReturn":0.042195,"FiveDayReturnAfter":-0.069398,"FiveDayReturnBefore":0.064194},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $110; previously $120.","DailyReturn":0.042195,"FiveDayReturnAfter":-0.069398,"FiveDayReturnBefore":0.064194},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $120; previously $155.","DailyReturn":0.042195,"FiveDayReturnAfter":-0.069398,"FiveDayReturnBefore":0.064194},{"Ticker":"FFIV","EffectiveDate":"2012-07-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.074433,"FiveDayReturnAfter":-0.025608,"FiveDayReturnBefore":0.004369},{"Ticker":"FFIV","EffectiveDate":"2012-07-18","Type":"RevenueBeat","Title":"After market close, FFIV reports 2012 Q3's earning $1.14 per share and revenue $352.6MM. This meets analyst's estimated EPS $1.14, misses estimated revenue $352.86MM.","DailyReturn":0.074433,"FiveDayReturnAfter":-0.025608,"FiveDayReturnBefore":0.004369},{"Ticker":"FFIV","EffectiveDate":"2012-07-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.074433,"FiveDayReturnAfter":-0.025608,"FiveDayReturnBefore":0.004369},{"Ticker":"FFIV","EffectiveDate":"2012-07-16","Type":"RatingNeutral","Title":"Morgan Stanley maintains FFIV to Overweight. Target Price is $125; previously $155.","DailyReturn":0.007878,"FiveDayReturnAfter":0.050253,"FiveDayReturnBefore":-0.033356},{"Ticker":"FFIV","EffectiveDate":"2012-07-13","Type":"RatingNeutral","Title":"Sterne Agee maintains FFIV to Buy. Target Price is $121; previously $141.","DailyReturn":-0.022253,"FiveDayReturnAfter":0.094658,"FiveDayReturnBefore":-0.081825},{"Ticker":"FFIV","EffectiveDate":"2012-07-13","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $117; previously $130.","DailyReturn":-0.022253,"FiveDayReturnAfter":0.094658,"FiveDayReturnBefore":-0.081825},{"Ticker":"FFIV","EffectiveDate":"2012-06-11","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains FFIV to Hold. Target Price is $110; previously $145.","DailyReturn":-0.022266,"FiveDayReturnAfter":-0.002346,"FiveDayReturnBefore":0.050985},{"Ticker":"FFIV","EffectiveDate":"2012-05-31","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $120; previously $140.","DailyReturn":-0.037753,"FiveDayReturnAfter":-0.040516,"FiveDayReturnBefore":-0.080373},{"Ticker":"FFIV","EffectiveDate":"2012-05-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.004422,"FiveDayReturnAfter":-0.109402,"FiveDayReturnBefore":-0.070332},{"Ticker":"FFIV","EffectiveDate":"2012-05-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.004422,"FiveDayReturnAfter":-0.109402,"FiveDayReturnBefore":-0.070332},{"Ticker":"FFIV","EffectiveDate":"2012-05-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $140; previously $150.","DailyReturn":-0.078751,"FiveDayReturnAfter":-0.12995,"FiveDayReturnBefore":-0.003559},{"Ticker":"FFIV","EffectiveDate":"2012-05-17","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.015136,"FiveDayReturnAfter":-0.003559,"FiveDayReturnBefore":-0.089945},{"Ticker":"FFIV","EffectiveDate":"2012-04-23","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on FFIV to Overweight. Target Price is $155.","DailyReturn":-0.005926,"FiveDayReturnAfter":0.033466,"FiveDayReturnBefore":0.074991},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $150; previously $135.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $134; previously $122.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"Miller Tabak maintains FFIV to Buy. Target Price is $165; previously $160.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $140; previously $127.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $125; previously $112.5.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingUpgrade","Title":"Wunderlich upgrades FFIV to Buy from Hold. Target Price is $145; previously $120.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $155; previously $135.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"ISI Group maintains FFIV to Buy. Target Price is $150; previously $130.","DailyReturn":0.078657,"FiveDayReturnAfter":0.051082,"FiveDayReturnBefore":0.01264},{"Ticker":"FFIV","EffectiveDate":"2012-04-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.003717,"FiveDayReturnAfter":0.043715,"FiveDayReturnBefore":-0.036106},{"Ticker":"FFIV","EffectiveDate":"2012-04-18","Type":"EarningsRelease","Title":"After market close, FFIV reports 2012 Q2's earning $0.86 per share and revenue $339.622MM..","DailyReturn":0.003717,"FiveDayReturnAfter":0.043715,"FiveDayReturnBefore":-0.036106},{"Ticker":"FFIV","EffectiveDate":"2012-04-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003717,"FiveDayReturnAfter":0.043715,"FiveDayReturnBefore":-0.036106},{"Ticker":"FFIV","EffectiveDate":"2012-04-16","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $122; previously $120.","DailyReturn":-0.000655,"FiveDayReturnAfter":0.074991,"FiveDayReturnBefore":-0.107135},{"Ticker":"FFIV","EffectiveDate":"2012-04-13","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $150; previously $125.","DailyReturn":-0.016351,"FiveDayReturnAfter":0.076201,"FiveDayReturnBefore":-0.091973},{"Ticker":"FFIV","EffectiveDate":"2012-04-09","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades FFIV to Hold from Buy. Target Price is $140.","DailyReturn":-0.022438,"FiveDayReturnAfter":-0.107135,"FiveDayReturnBefore":0.007902},{"Ticker":"FFIV","EffectiveDate":"2012-04-03","Type":"RatingNeutral","Title":"Oppenheimer maintains FFIV to Outperform. Target Price is $150; previously $130.","DailyReturn":0.010244,"FiveDayReturnAfter":-0.063126,"FiveDayReturnBefore":0.013705},{"Ticker":"FFIV","EffectiveDate":"2012-04-03","Type":"RatingNeutral","Title":"Bank oferica maintains FFIV to Buy. Target Price is $145; previously $136.","DailyReturn":0.010244,"FiveDayReturnAfter":-0.063126,"FiveDayReturnBefore":0.013705},{"Ticker":"FFIV","EffectiveDate":"2012-04-02","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $130.","DailyReturn":0.012596,"FiveDayReturnAfter":-0.015534,"FiveDayReturnBefore":0.021194},{"Ticker":"FFIV","EffectiveDate":"2012-03-28","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $147; previously $125.","DailyReturn":-0.000447,"FiveDayReturnAfter":0.029029,"FiveDayReturnBefore":0.034902},{"Ticker":"FFIV","EffectiveDate":"2012-03-28","Type":"RatingNeutral","Title":"FBN Securities downgrades FFIV to Sector Perform from Outperform. Target Price is $135; previously $125.","DailyReturn":-0.000447,"FiveDayReturnAfter":0.029029,"FiveDayReturnBefore":0.034902},{"Ticker":"FFIV","EffectiveDate":"2012-03-19","Type":"RatingNeutral","Title":"Sterne Agee maintains FFIV to Buy. Target Price is $141; previously $123.","DailyReturn":0.006216,"FiveDayReturnAfter":0.001666,"FiveDayReturnBefore":0.048938},{"Ticker":"FFIV","EffectiveDate":"2012-03-15","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.003413,"FiveDayReturnAfter":-0.003799,"FiveDayReturnBefore":0.055428},{"Ticker":"FFIV","EffectiveDate":"2012-03-07","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on FFIV to Hold. Target Price is $145.","DailyReturn":0.028781,"FiveDayReturnAfter":0.090304,"FiveDayReturnBefore":-0.046408},{"Ticker":"FFIV","EffectiveDate":"2012-03-05","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $127; previously $110.","DailyReturn":-0.019841,"FiveDayReturnAfter":-0.011085,"FiveDayReturnBefore":-0.003693}];